Moderators and speakers of the 10th AMR Conference
Benoît Hennion
Co-Founder & Co-CEO, Tamrisa
Betsy Wonderly Trainor
Alliance Director Diagnostics, CARB-X
Carmen Coxon
Regulatory Scientist, UK Medicines and Healthcare Products Regulatory Agency (MHRA)
César de la Fuente
Presidential Associate Professor, University of Pennsylvania
Christoph Dehio
Professor of Molecular Microbiology at Biozentrum, University of Basel, and Director of the NCCR AntiResist
David Paterson
Professor ADVANCE-ID, National University of Singapore
Florence Séjourné
CEO, AUROBAC THERAPEUTICS & Board Member and Founder, BEAM Alliance
Guillermo Tramontin
Associate Partner, Cavenagh Health
Hee-Jong (Jason) Hwang
CEO, A&J Science
Jan Rybniker
Professor and Head of Infectious Diseases, University Hospital Cologne
John Rex
Chief Medical Officer, F2G Ltd. & Operating Partner, Advent Life Sciences
Kevin Outterson
Austin B Fletcher Professor, Boston University, and Executive Director & Principal Investigator, CARB-X
Kristof Van Emelen
CEO, Obulytix
Lauriane Cabon
Group Lead at the Institute of Human Biology, F. Hoffmann-La Roche
Leela Maitreyi
Director Business Development, Strategy and Global Collaborations, Bugworks Research
Lucas Boeck
Consultant Pulmonary Medicine, University Hospital Basel
Marc Gitzinger
CEO, BioVersys AG & President, BEAM Alliance
Marc Lemonnier
CEO, Antabio SAS
Martin Everett
CSO, AUROBAC THERAPEUTICS
Mihai Rotaru
Director Market Access, EFPIA
Morgane Vanbiervliet
Director, Global Business Development & Licensing, Debiopharm International SA
Peter Beyer
Deputy Executive Director, GARDP Foundation
Radu Botgros
Senior Scientific Officer, European Medicines Agency
Richard Alm
Chief Scientific Officer, CARB-X
Rienk Pypstra
Chief Medical Officer & Head of Infectious Diseases, tranScrip
Subhendu Basu
CEO & Board member, Telum Therapeutics
Tom Loughman
Board Member, Helperby Therapeutics Group Ltd.
Valeria Gigante
AMR R&D Lead, World Health Organization
Yann Ferrisse
Director, Business Development & Partner Engagement, Global Access at Global Antibiotic R&D Partnership (GARDP)